Alternative methods in cardiovascular tissue engineering

Tissue Engineering: Roles, Materials and Applications

Volumn , Issue , 2008, Pages 275-285

  De Visscher, Geofrey ^a   Flameng, Willem ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85030586184     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (54)

1. Campbell, JH; Efendy, JL; Campbell, GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ. Res. 1999 85, 1173-1178
2. De Visscher, G; Vranken, I; Lebacq, A; Van Kerrebroeck, C; Ganame, J; Verbeken, E; Flameng, W. In vivo cellularisation of a cross-linked matrix by intraperitoneal implantation: a new tool in heart valve tissue engineering. Eur. Heart J. 2007 28, 1389-1396
3. Flameng, W. A new approach to heart valve tissue engineering. Int. J. Cardiol. 2004 95 Suppl. 1, S55-S56
4. Ota, T; Sawa, Y; Iwai, S; Kitajima, T; Ueda, Y; Coppin, C; Matsuda, H; Okita, Y. Fibronectin-hepatocyte growth factor enhances reendothelialization in tissueengineered heart valve. Ann. Thorac. Surg. 2005 80, 1794-1801.
5. Lal, B; Viola, J; Hicks, D; Grad O. NSF: Abt report on "The Emergence of Tissue Engineering as a Research Field". 2003
6. Langer, R; Vacanti, JP. Tissue engineering. Science. 1993 260, 920-926
7. Fenn, J. Understanding Gartner's Hype Cycle, 2007. 2007 G00144727
8. Shinoka, T; Breuer, CK; Tanel, RE; Zund, G; Miura, T; Ma, PX; Langer, R; Vacanti, JP; Mayer, JE, Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 1995 60, S513-S516
9. Rabkin, E; Schoen, FJ. Cardiovascular tissue engineering. Cardiovasc. Pathol. 2002 11, 305-317
10. Hoerstrup, SP; Sodian, R; Daebritz, S; Wang, J; Bacha, EA; Martin, DP; Moran, AM; Guleserian, KJ; Sperling, JS; Kaushal, S; Vacanti, JP; Schoen, FJ; Mayer, JE, Jr. Functional living trileaflet heart valves grown in vitro. Circulation. 2000 102, III44-III49
11. Dohmen, PM; Ozaki, S; Verbeken, E; Yperman, J; Flameng, W; Konertz, WF. Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovasc. Thorac. Ann. 2002 10, 25-30
12. Gabbieri, D; Dohmen, PM; Linneweber, J; Lembcke, A; Braun, JP; Konertz, W. Ross procedure with a tissue-engineered heart valve in complex congenital aortic valve disease. J. Thorac. Cardiovasc. Surg. 2007 133, 1088-1089
13. Orlic, D; Kajstura, J; Chimenti, S; Limana, F; Jakoniuk, I; Quaini, F; Nadal-Ginard, B; Bodine, DM; Leri, A; Anversa, P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U.S.A. 2001 98, 10344-10349
14. Janssens, S; Dubois, C; Bogaert, J; Theunissen, K; Deroose, C; Desmet, W; Kalantzi, M; Herbots, L; Sinnaeve, P; Dens, J; Maertens, J; Rademakers, F; Dymarkowski, S; Gheysens, O; Van Cleemput, J; Bormans, G; Nuyts, J; Belmans, A; Mortelmans, L; Boogaerts, M; Van de, WF. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006 367, 113-121
15. Vincentelli, A; Wautot, F; Juthier, F; Fouquet, O; Corseaux, D; Marechaux, S; Le Tourneau, T; Fabre, O; Susen, S; Van Belle, E; Mouquet, F; Decoene, C; Prat, A; Jude, B. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates? J. Thorac. Cardiovasc. Surg. 2007 134, 424-432
16. De Visscher, G; Blockx H; Vranken, I; Verbeken, E; Van Oosterwyck H; Herregods, MC; Meuris, B; Flameng, W. Enhanced in situ recellularization by fibronectin and stromal cell derived factor-1alpha coating of heart valves acquires a quasi-native valve composition of cell phenotypes. Circulation. 2007 116 (suppl), II-446
17. Zimmermann, WH; Didie, M; Wasmeier, GH; Nixdorff, U; Hess, A; Melnychenko, I; Boy, O; Neuhuber, WL; Weyand, M; Eschenhagen, T. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation. 2002 106, I151-I157
18. The Culture of Organs. Can. Med. Assoc. J. 1938 39, 416-
19. Voorhees, AB. How it all began. In: Sawyer, PN and Kaplitt, M. J. editors. Vascular grafts. New York: Appleton-Century-Crofts; 1978; 3-4.
20. Eiken, O. Autogenous connective tissue tubes for replacement of small artery defects. A preliminary report of an experimental study in dogs. Acta Chir. Scand. 1960 120, 47-50.
21. Schilling, JA; Shurley, HM; Joel, W; Richter, KM; White, BN. Fibrocollagenous tubes structured in vivo. Morphology and biological characteristics. Arch. Pathol. 1961 71, 548-553
22. Schilling, JA; Shurley, HM; Joel, W; White, BN; Bradford, RH. Abdominal aortic grafts: Use of in vivo structured autologous and homologous fibrocollagenous tubes. Ann. Surg. 1964 159, 819-828
23. Sparks, CH. Die-grown reinforced arterial grafts: observations on long-term animal grafts and clinical experience. Ann. Surg. 1970 172, 787-794
24. Sparks, CH. Silicone mandril method for growing reinforced autogenous femoropopliteal artery grafts in situ. Ann. Surg. 1973 177, 293-300
25. Sparks, CH. Silicone mandril method of femoropopliteal artery bypass. Clinical experience and surgical technics. Am. J. Surg. 1972 124, 244-249
26. Hallin, RW; Sweetman, WR. The Sparks' mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates. Am. J. Surg. 1976 132, 221-223
27. Roberts, PN; Hopkinson, BR. The Sparks mandril in femoropopliteal bypass. Br. Med. J. 1977 2, 1190-1191
28. Rosengren, A; Danielsen, N; Bjursten, LM. Inflammatory reaction dependence on implant localization in rat soft tissue models. Biomaterials. 1997 18, 979-987
29. Chue, WL; Campbell, GR; Caplice, N; Muhammed, A; Berry, CL; Thomas, AC; Bennett, MB; Campbell, JH. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J. Vasc. Surg. 2004 39, 859-867
30. Campbell, JH; Efendy, JL; Han, C; Girjes, AA; Campbell, GR. Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. J. Vasc. Res. 2000 37, 364-371
31. Campbell, JH; Efendy, JL; Han, CL; Campbell, GR. Blood vessels from bone marrow. Ann. N.Y. Acad. Sci. 2000 902, 224-229
32. Bayes-Genis, A; Campbell, JH; Carlson, PJ; Holmes, DR, Jr; Schwartz, RS. Macrophages, myofibroblasts and neointimal hyperplasia after coronary artery injury and repair. Atherosclerosis. 2002 163, 89-98
33. Jabs, A; Moncada, GA; Nichols, CE; Waller, EK; Wilcox, JN. Peripheral blood mononuclear cells acquire myofibroblast characteristics in granulation tissue. J. Vasc. Res. 2005 42, 174-180
34. Ninomiya, K; Takahashi, A; Fujioka, Y; Ishikawa, Y; Yokoyama, M. Transforming growth factor-beta signaling enhances transdifferentiation of macrophages into smooth muscle-like cells. Hypertens. Res. 2006 29, 269-276
35. Schmitt-Graff, A; Desmouliere, A; Gabbiani, G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch. 1994 425, 3-24
36. Galmiche, MC; Koteliansky, VE; Briere, J; Herve, P; Charbord, P. Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood. 1993 82, 66-76
37. Bonanno, E; Ercoli, L; Missori, P; Rocchi, G; Spagnoli, LG. Homogeneous stromal cell population from normal human adult bone marrow expressing alpha-smooth muscle actin filaments. Lab. Invest. 1994 71, 308-315.
38. Vranken, I; De Visscher, G; Lebacq, A; Verbeken, E; Flameng, W. The recruitment of primitive Lin-Sca-1+, CD34+, C-kit+ and CD271+ cells during the early intraperitoneal foreign body reaction. Biomaterials. 2008 29(7), 797-808
39. De Visscher, G; Blockx H; Meuris, B; Van Oosterwyck H; Verbeken, E; Herregods, MC; Flameng, W. Functional and biomechanical evaluation of a completely recellularized stentless pulmonary bioprosthesis in sheep. J. Thorac. Cardiovasc. Surg. 2008 135(2), 395-404
40. Morritt, AN; Bortolotto, SK; Dilley, RJ; Han, X; Kompa, AR; McCombe, D; Wright, CE; Itescu, S; Angus, JA; Morrison, WA. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation. 2007 115, 353-360
41. Pierschbacher, MD; Ruoslahti, E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc. Natl. Acad. Sci. U.S.A. 1984 81, 5985-5988
42. Tiwari, A; Salacinski, HJ; Punshon, G; Hamilton, G; Seifalian, AM. Development of a hybrid cardiovascular graft using a tissue engineering approach. FASEB J. 2002 16, 791-796
43. Quirk, RA; Chan, WC; Davies, MC; Tendler, SJ; Shakesheff, KM. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials. 2001 22, 865-872
44. Alobaid, N; Salacinski, HJ; Sales, KM; Ramesh, B; Kannan, RY; Hamilton, G; Seifalian, AM. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur. J. Vasc. Endovasc. Surg. 2006 32, 76-83
45. Burgess, BT; Myles, JL; Dickinson, RB. Quantitative analysis of adhesion-mediated cell migration in three-dimensional gels of RGD-grafted collagen. Ann. Biomed. Eng. 2000 28, 110-118
46. Stephan, S; Ball, SG; Williamson, M; Bax, DV; Lomas, A; Shuttleworth, CA; Kielty, CM. Cell-matrix biology in vascular tissue engineering. J. Anat. 2006 209, 495-502
47. Denhardt, DT; Guo, X. Osteopontin: a protein with diverse functions. FASEB J. 1993 7, 1475-1482
48. Turner, NJ; Kielty, CM; Walker, MG; Canfield, AE. A novel hyaluronan-based biomaterial (Hyaff-11) as a scaffold for endothelial cells in tissue engineered vascular grafts. Biomaterials. 2004 25, 5955-5964
49. Bussolino, F; Di Renzo, MF; Ziche, M; Bocchietto, E; Olivero, M; Naldini, L; Gaudino, G; Tamagnone, L; Coffer, A; Comoglio, PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 1992 119, 629-641
50. Guarita-Souza, LC; Carvalho, KA; Woitowicz, V; Rebelatto, C; Senegaglia, A; Hansen, P; Miyague, N; Francisco, JC; Olandoski, M; Faria-Neto, JR; Brofman, P. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation. 2006 114, I120-I124
51. Lebacq, A; De Visscher, G; Vranken, I; Flameng, W. Homing, signaling, and structural molecule gene xpression profiling in the early-phase foreign body reaction. Int.J.Lower Extremity Wounds. 2007 6, 198
52. Della Rocca, F; Sartore, S; Guidolin, D; Bertiplaglia, B; Gerosa, G; Casarotto, D; Pauletto, P. Cell composition of the human pulmonary valve: a comparative study with the aortic valve--the VESALIO Project. Vitalitate Exornatum Succedaneum Aorticum labore Ingegnoso Obtinebitur. Ann. Thorac. Surg. 2000 70, 1594-1600
53. Mendelson, K; Schoen, FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann. Biomed. Eng. 2006 34, 1799-1819
54. Askari, AT; Unzek, S; Popovic, ZB; Goldman, CK; Forudi, F; Kiedrowski, M; Rovner, A; Ellis, SG; Thomas, JD; DiCorleto, PE; Topol, EJ; Penn, MS. Effect of stromal-cellderived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003 362, 697-703.